Xencor reported $10.84M in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
Alnylam Pharmaceuticals ALNY:US $ -134.35M 39.3M
Amgen AMGN:US $ 3188M 218M
Arrowhead Research ARWR:US $ -29868000 3.56M
AstraZeneca AZN:LN 2149M 322M
Biogen BIIB:US $ 991.8M 155.8M
Bristol Myers Squibb BMY:US $ 5679M 455M
Cytokinetics CYTK:US $ -54.25M 14.18M
Epizyme EPZM:US $ -55.92M 6.14M
GlaxoSmithKline GSK:LN 2626M 584M
Johnson & Johnson JNJ:US $ 8192M 2043M
Karyopharm Therapeutics KPTI:US $ -48819000 3.32M
Macrogenics MGNX:US $ -37498000 11.07M
Novartis NOVN:VX SF 4772M 423M
Pfizer PFE:US $ 7593M 610M
Regeneron Pharmaceuticals REGN:US $ 3418.3M 2238.2M
Seattle Genetics SGEN:US $ -73.78M 33.35M
Xencor XNCR:US $ 10.84M 24.87M